NeuroHealing Adds Leading Experts to NH02D Program Medical Advisory Board
Newton, Massachusetts – June 2015. NeuroHealing Pharmaceuticals, a private, clinical stage company developing innovative drug treatments for specialty indications based on repositioning neurologically active compounds, announces two additions to the Medical Advisory Board (MAB) to advise on the company’s NH02D program for the treatment of premature ejaculation (PE). The MAB assists NeuroHealing in the scientific and…